湖北地区306例极重度聋患儿基因芯片筛查分析

詹悦, 吴瑕, 胡钰娟, 等. 湖北地区306例极重度聋患儿基因芯片筛查分析[J]. 临床耳鼻咽喉头颈外科杂志, 2014, 28(10): 680-684. doi: 10.13201/j.issn.1001-1781.2014.10.004
引用本文: 詹悦, 吴瑕, 胡钰娟, 等. 湖北地区306例极重度聋患儿基因芯片筛查分析[J]. 临床耳鼻咽喉头颈外科杂志, 2014, 28(10): 680-684. doi: 10.13201/j.issn.1001-1781.2014.10.004
ZHAN Yue, WU Xia, HU Yujuan, et al. DNA microarray screening analysis in children with profound hearing impairment in Hubei province[J]. J Clin Otorhinolaryngol Head Neck Surg, 2014, 28(10): 680-684. doi: 10.13201/j.issn.1001-1781.2014.10.004
Citation: ZHAN Yue, WU Xia, HU Yujuan, et al. DNA microarray screening analysis in children with profound hearing impairment in Hubei province[J]. J Clin Otorhinolaryngol Head Neck Surg, 2014, 28(10): 680-684. doi: 10.13201/j.issn.1001-1781.2014.10.004

湖北地区306例极重度聋患儿基因芯片筛查分析

  • 基金项目:

    国家重点基础研究发展计划(973计划,No:2011CB504504);卫生部行业基金《耳聋出生缺陷预防和干预规范化及推广应用》(No:201202005);卫生部行业专项《国产人工耳蜗优化及临床技术研究》(No:201202001)

详细信息
    通讯作者: 孔维佳,E-mail:entwjkong@hust.edu.cn
  • 中图分类号: R764.43

DNA microarray screening analysis in children with profound hearing impairment in Hubei province

More Information
  • 目的:通过检测湖北地区极重度感音神经性聋患儿常见耳聋基因突变情况,分析该人群的分子病因学特点,为临床耳聋防治和遗传咨询提供参考。方法:收集306例湖北地区极重度感音神经性聋患儿,抽取外周血,提取DNA,应用遗传性耳聋基因芯片检测GJB2、GJB3、SLC26A4和线粒体12SrRNA 4个基因的9个突变热点。对所有携带SLC26A4基因突变患者进行颞骨CT扫描。结果:306名患儿中,132例(43.14%)检出携带不同基因突变,其中有2例携带双基因突变。GJB2基因突变检出率为29.41%(90/306),SLC26A4基因突变检出率为13.72%(42/306),线粒体12SrRNA基因突变检出率为0.65%(2/306)。本组患者未检出GJB3基因突变。36例携带SLC26A4基因突变者颞骨CT扫描显示前庭水管扩大。结论:GJB2基因和SLC26A4基因是本组患儿最主要的致聋基因,其中235delC突变为最常见的突变位点,其次为IVS7-2A>G突变。筛查SLC26A4基因常见突变有助于大前庭水管综合征的诊断。
  • 加载中
  • [1]

    KORVER A M,ADMIRAALl R J,KANT S G,et al. Causes of permanent childhood hearing impairment[J]. Laryngoscope,2011,121:409-416.

    [2]

    韩明昱,戴朴. 我国耳聋基因诊断的临床应用进展[J]. 北京医学,2011,33(5):419-421.

    [3]

    李海波,李琼,李红,等. 非综合征性聋突变热点的流行病学分析[J]. 临床耳鼻咽喉头颈外科杂志,2012,26(13):589-594.

    [4]

    CHAN D K,CHANK K W. GJB2-associated hearing loss:systematic review of worldwide prevalence, genotype, and auditory phenotype[J]. Laryngoscope,2014,124:E34-E53.

    [5]

    姜鸿,陈晓巍. 耳聋基因诊断[J]. 协和医学杂志,2012,3(2):134-137.

    [6]

    于飞,韩东一,戴朴,等. 1190例非综合征性耳聋患者GJB2基因突变序列分析[J]. 中华医学杂志,2007,87(40):2814-2819.

    [7]

    DAI P,YU F,HAN B,LIU X,et al. GJB2 mutation spectrum in 2063 Chinese patients with nonsyndromic hearing impairment[J]. J Transl Med,2009,7:26-26.

    [8]

    马建鹂,徐百成,边盼盼,等. 中国西北地区回族非综合征型聋患者耳聋相关基因研究[J]. 听力学及言语疾病杂志,2013,20(5):451-455.

    [9]

    陈俞,玛依拉·吐地,张华,等. 新疆维吾尔族与汉族非综合征性耳聋患者四个耳聋基因突变谱的筛查[J]. 中华检验医学杂志,2010,33(11):1083-1087.

    [10]

    OUYANG X M,YAN D,YUAN H J,et al. The genetic bases for non-syndromic hearing loss among Chinese[J]. J Hum Genet,2009,4:131-140.

    [11]

    CAMPBELL C,CUCCI R A,PRASAD S,et al. Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations[J]. Hum Mutat,2001,17:403-411.

    [12]

    TSUKAMOTO K,SUZUKI H,HARADA D,et al. Distribution and frequencies of PDS (SLC26A4) mutations in Pendred syndrome and nonsyndromic hearing loss associated with enlarged vestibular aqueduct:a unique spectrum of mutations in Japan[J]. Eur J Hum Genet,2003,11:916-922.

    [13]

    WANG Q J,ZHAO Y L,RAO S Q,et al. A distinct spectrum of SLC26A4 mutations in patients with enlarged vestibular aqueduct in China[J].Clin Genet,2007,72:245-254.

    [14]

    DAI P,STEWART A K,CHEBIB F,et al. Distinct and novel SLC26A4/Pendrin mutations in Chinese and US patients with nonsyndromic hearing loss[J]. Physiol Genomics,2009,38:281-290.

    [15]

    YUAN Y,GUO W,TANG J,et al. Molecular epidemiology and functional assessment of novel allelic variants of SLC26A4 in non-syndromic hearing loss patients with enlarged vestibular aqueduct in China[J]. PLoS One,2012,7:e49984.

    [16]

    ZHAO J,YUAN Y,CHEN J,et al. SLC26A4 gene copy number variations in Chinese patients with non-syndromic enlarged vestibular aqueduct.[J]. J Transl Med,2012,10:82-82.

    [17]

    李琦,黄德亮,朱庆文,等. 感音神经性耳聋患者大前庭导水管综合征相关SLC26A4基因IVS7-2A>G的全序列分析[J]. 中华医学遗传学杂志,2010,27(6):610-615.

    [18]

    朱发梅,胡鹏,赖若沙,等. 基因芯片联合DNA测序法在大前庭水管综合征患者基因诊断中的应用[J]. 中华耳科学杂志,2011,9(2):168-173.

    [19]

    柴永川.SLC26A4基因突变在耳聋疾病中的作用[J].听力学及言语疾病杂志,2011,19(4):376-379.

    [20]

    刘新,戴朴,黄德亮,等. 线粒体DNA A1555G突变大规模筛查及其预防意义探讨[J]. 中华医学杂志,2006,86(19):1318-1322.

    [21]

    鲍晓林,郭玉芬,刘晓雯,等. 西北地区与东北地区耳聋先证者线粒体DNA12SrRNA A1555G突变特点分析[J]. 听力学及言语疾病杂志,2010,18(4):387-388.

    [22]

    李琦,戴朴,方如平,等. 线粒体DNA A1555G突变在中国不同经济发展地区耳聋人群的对比研究[J]. 中国听力语言康复科学杂志,2009,4(1):13-17.

    [23]

    CHEN G,HE F,FU S,et al. GJB2 and mitochondrial DNA 1555A>G mutations in students with hearing loss in the Hubei Province of China[J]. Int J Pediatr Otorhinolaryngol,2011,75:1156-1159.

    [24]

    邓蔚,于飞,戴朴,等. 武汉地区非综合征性聋分子病因学分析——GJB2235delC突变和线粒体DNA 12SrRNA A1555G突变筛查报告[J]. 中华耳科学杂志,2006,4(1):24-26.

  • 加载中
计量
  • 文章访问数:  49
  • PDF下载数:  33
  • 施引文献:  0
出版历程
收稿日期:  2013-03-10

目录